Recombinant viral vaccines expressing merozoite surface protein-1 induce antibody- and T cell-mediated multistage protection against malaria.

Recombinant viral vaccines expressing merozoite surface protein-1 induce antibody- and T cell-mediated multistage protection against malaria.

Protecting against both liver and blood stages of infection is a long-sought goal of malaria vaccine design. Recently, we described the use of replication-defective viral vaccine vectors expressing the malaria antigen merozoite surface protein-1 (MSP-1) as an antimalarial vaccine strategy that elici...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Draper, S, Goodman, A, Biswas, S, Forbes, E, Moore, A, Gilbert, S, Hill, A
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2009

Míreanna comhchosúla

Recombinant Viral Vaccines Expressing Merozoite Surface Protein-1 Induce Antibody- and T Cell-Mediated Multistage Protection against Malaria (vol 5, pg 95, 2009)
de réir: Draper, S, et al.
Foilsithe / Cruthaithe: (2011)

The utility of Plasmodium berghei as a rodent model for anti-merozoite malaria vaccine assessment
de réir: Goodman, A, et al.
Foilsithe / Cruthaithe: (2013)

Recombinant viral-vectored vaccines expressing Plasmodium chabaudi AS apical membrane antigen 1: mechanisms of vaccine-induced blood-stage protection.
de réir: Biswas, S, et al.
Foilsithe / Cruthaithe: (2012)

Combining liver- and blood-stage malaria viral-vectored vaccines: investigating mechanisms of CD8+ T cell interference.
de réir: Forbes, E, et al.
Foilsithe / Cruthaithe: (2011)

Effective induction of high-titer antibodies by viral vector vaccines.
de réir: Draper, S, et al.
Foilsithe / Cruthaithe: (2008)

Complete protective immunity against blood-stage malaria induced by heterologous prime-boost vaccination
de réir: Draper, S, et al.
Foilsithe / Cruthaithe: (2005)

Assessment of anti-merozoite antibody function in the context of blood-stage malaria vaccine development
de réir: Llewellyn, D
Foilsithe / Cruthaithe: (2014)

Opsonising antibodies to P. falciparum merozoites associated with immunity to clinical malaria.
de réir: Danika L Hill, et al.
Foilsithe / Cruthaithe: (2013-01-01)

The structure of Plasmodium yoelii merozoite surface protein 119, antibody specificity and implications for malaria vaccine design
de réir: Rachel D. Curd, et al.
Foilsithe / Cruthaithe: (2014-01-01)

A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria
de réir: Murungi, L, et al.
Foilsithe / Cruthaithe: (2013)

A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria.
de réir: Murungi, L, et al.
Foilsithe / Cruthaithe: (2013)

Anti-CD25 antibody enhancement of vaccine-induced immunogenicity to bacterial, viral and parasitic antigens: increased durable cellular immunity with reduced immunodominance
de réir: Moore, A, et al.
Foilsithe / Cruthaithe: (2005)

Recent advances in recombinant protein-based malaria vaccines.
de réir: Draper, S, et al.
Foilsithe / Cruthaithe: (2015)

Plasmodium falciparum Merozoite Associated Armadillo Protein (PfMAAP) Is Apically Localized in Free Merozoites and Antibodies Are Associated With Reduced Risk of Malaria
de réir: Yaw Aniweh, et al.
Foilsithe / Cruthaithe: (2020-04-01)

Allele-specific antibodies to Plasmodium falciparum merozoite surface protein-2 and protection against clinical malaria.
de réir: Osier, F, et al.
Foilsithe / Cruthaithe: (2010)

Antibody responses to a novel Plasmodium falciparum merozoite surface protein vaccine correlate with protection against experimental malaria infection in Aotus monkeys.
de réir: David R Cavanagh, et al.
Foilsithe / Cruthaithe: (2014-01-01)

Production and Characterization of Polyclonal Anti-idiotypic Antibody to Malaria Merozoite Antigen
de réir: Jiraporn Suwan, et al.
Foilsithe / Cruthaithe: (2015-02-01)

Progress with viral vectored malaria vaccines: A multi-stage approach involving “unnatural immunity”
de réir: Ewer, K, et al.
Foilsithe / Cruthaithe: (2015)

Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria.
de réir: Osier, F, et al.
Foilsithe / Cruthaithe: (2008)

New candidate vaccines against blood-stage Plasmodium falciparum malaria: prime-boost immunization regimens incorporating human and simian adenoviral vectors and poxviral vectors expressing an optimized antigen based on merozoite surface protein 1.
de réir: Goodman, A, et al.
Foilsithe / Cruthaithe: (2010)

EVALUATION OF SIMIAN ADENOVIRAL VECTOR ADCH63 EXPRESSING MSP-1 AS A CANDIDATE BLOOD-STAGE MALARIA VACCINE
de réir: Goodman, A, et al.
Foilsithe / Cruthaithe: (2009)

Association of antibody responses to the conserved Plasmodium falciparum merozoite surface protein 5 with protection against clinical malaria.
de réir: Ronald Perraut, et al.
Foilsithe / Cruthaithe: (2014-01-01)

A viral vectored prime-boost immunization regime targeting the malaria Pfs25 antigen induces transmission-blocking activity.
de réir: Goodman, A, et al.
Foilsithe / Cruthaithe: (2011)

Differing rates of antibody acquisition to merozoite antigens in malaria: implications for immunity and surveillance
de réir: McCallum, FJ, et al.
Foilsithe / Cruthaithe: (2016)

Plasmodium falciparum Merozoite Associated Armadillo Protein (PfMAAP) is apically localized in free merozoites and antibodies are associated with reduced risk of malaria
de réir: Aniweh, Y, et al.
Foilsithe / Cruthaithe: (2020)

Multistage protective anti-CelTOS monoclonal antibodies with cross-species sterile protection against malaria
de réir: Wai Kwan Tang, et al.
Foilsithe / Cruthaithe: (2024-08-01)

Evaluation of recombinant plasmodium knowlesi merozoite surface Protein-1(33) for detection of human Malaria
de réir: Cheong, F.W., et al.
Foilsithe / Cruthaithe: (2013)

Breadth of anti-merozoite antibody responses is associated with the genetic diversity of asymptomatic Plasmodium falciparum infections and protection against clinical malaria.
de réir: Rono, J, et al.
Foilsithe / Cruthaithe: (2013)

Blood-stage malaria vaccines - recent progress and future challenges.
de réir: Goodman, A, et al.
Foilsithe / Cruthaithe: (2010)

The requirement for potent adjuvants to enhance the immunogenicity and protective efficacy of protein vaccines can be overcome by prior immunization with a recombinant adenovirus.
de réir: de Cassan, S, et al.
Foilsithe / Cruthaithe: (2011)

Differential antibody responses to Plasmodium falciparum merozoite proteins in Malawian children with severe malaria.
de réir: Dobaño, C, et al.
Foilsithe / Cruthaithe: (2008)

Antibody responses to the merozoite surface protein-1 complex in cerebral malaria patients in India
de réir: Dash Aditya P, et al.
Foilsithe / Cruthaithe: (2008-07-01)

New Candidate Vaccines against Blood-Stage Plasmodium falciparum Malaria: Prime-Boost Immunization Regimens Incorporating Human and Simian Adenoviral Vectors and Poxviral Vectors Expressing an Optimized Antigen Based on Merozoite Surface Protein 1, (vol 78, pg 4610, 2010)
de réir: Goodman, A, et al.
Foilsithe / Cruthaithe: (2011)

Neutralization of Plasmodium falciparum merozoites by antibodies against PfRH5.
de réir: Douglas, A, et al.
Foilsithe / Cruthaithe: (2014)

The immunoglobulin G antibody response to malaria merozoite antigens in asymptomatic children co-infected with malaria and intestinal parasites.
de réir: Crespo'o Mbe-Cho Ndiabamoh, et al.
Foilsithe / Cruthaithe: (2020-01-01)

Combination of protein and viral vaccines induces potent cellular and humoral immune responses and enhanced protection from murine malaria challenge.
de réir: Hutchings, C, et al.
Foilsithe / Cruthaithe: (2007)

New vectored vaccines for malaria.
de réir: Hill, A, et al.
Foilsithe / Cruthaithe: (2008)

A newly characterized malaria antigen on erythrocyte and merozoite surfaces induces parasite inhibitory antibodies
de réir: Michelow, Ian C, et al.
Foilsithe / Cruthaithe: (2021)

Viral vectored blood-stage malaria vaccines induce B cell responses in humans that can be boosted by controlled malaria infection
de réir: Elias, S, et al.
Foilsithe / Cruthaithe: (2014)

Assessment of immune interference, antagonism, and diversion following human immunization with biallelic blood-stage malaria viral-vectored vaccines and controlled malaria infection.
de réir: Elias, S, et al.
Foilsithe / Cruthaithe: (2013)